SRRT

serrate, RNA effector molecule

Basic information

Region (hg38): 7:100875103-100888664

Links

ENSG00000087087NCBI:51593OMIM:614469HGNC:24101Uniprot:Q9BXP5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SRRT gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRRT gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
5
clinvar
7
missense
56
clinvar
1
clinvar
57
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
2
clinvar
2
Total 0 0 56 3 7

Variants in SRRT

This is a list of pathogenic ClinVar variants found in the SRRT region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-100881319-G-A not specified Uncertain significance (Dec 09, 2024)3449632
7-100881346-C-T not specified Uncertain significance (May 07, 2024)3322747
7-100881355-C-T not specified Uncertain significance (Nov 25, 2024)3449618
7-100881371-G-A not specified Uncertain significance (Nov 01, 2022)2321733
7-100881398-G-C not specified Uncertain significance (Dec 17, 2021)2267877
7-100881712-G-C not specified Uncertain significance (Jan 23, 2024)3170247
7-100881764-C-T Likely benign (Mar 01, 2023)2657775
7-100882125-C-T Benign (Dec 11, 2018)778024
7-100884097-G-A Benign (Dec 31, 2019)770190
7-100884114-A-G not specified Uncertain significance (Sep 02, 2024)3449627
7-100884122-C-T not specified Uncertain significance (Jan 22, 2024)3170248
7-100884123-G-A not specified Uncertain significance (Jul 14, 2021)2224609
7-100884146-A-T not specified Uncertain significance (Aug 02, 2023)2615539
7-100884176-T-C not specified Uncertain significance (Oct 12, 2024)3449628
7-100884218-A-G not specified Uncertain significance (May 13, 2024)3322745
7-100884392-C-T not specified Uncertain significance (Aug 05, 2024)3449623
7-100884405-T-C Benign (Apr 03, 2020)1264019
7-100884407-G-A not specified Uncertain significance (Sep 20, 2023)3170249
7-100884457-C-T not specified Uncertain significance (Nov 10, 2024)3449619
7-100884461-G-A not specified Uncertain significance (Dec 17, 2024)3801678
7-100884473-A-G not specified Uncertain significance (Jun 16, 2024)3322742
7-100884502-G-A not specified Uncertain significance (Feb 22, 2025)3801685
7-100884508-C-T not specified Uncertain significance (May 17, 2024)3322743
7-100884509-G-A not specified Uncertain significance (Dec 17, 2024)3801675
7-100884527-A-C not specified Uncertain significance (Jul 29, 2022)2231926

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SRRTprotein_codingprotein_codingENST00000347433 1913553
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.5940.4061257140341257480.000135
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.973835850.6550.00003925771
Missense in Polyphen101183.180.551371828
Synonymous-2.092662261.180.00001521649
Loss of Function4.971046.70.2140.00000242529

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005750.000572
Ashkenazi Jewish0.00009920.0000992
East Asian0.0001090.000109
Finnish0.00009240.0000924
European (Non-Finnish)0.0001410.000141
Middle Eastern0.0001090.000109
South Asian0.00003290.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Acts as a mediator between the cap-binding complex (CBC) and the primary microRNAs (miRNAs) processing machinery during cell proliferation. Contributes to the stability and delivery of capped primary miRNA transcripts to the primary miRNA processing complex containing DGCR8 and DROSHA, thereby playing a role in RNA-mediated gene silencing (RNAi) by miRNAs. Binds capped RNAs (m7GpppG-capped RNA); however interaction is probably mediated via its interaction with NCBP1/CBP80 component of the CBC complex. Involved in cell cycle progression at S phase. Does not directly confer arsenite resistance but rather modulates arsenic sensitivity. Independently of its activity on miRNAs, necessary and sufficient to promote neural stem cell self-renewal. Does so by directly binding SOX2 promoter and positively regulating its transcription (By similarity). {ECO:0000250, ECO:0000269|PubMed:19632182}.;
Pathway
Gene expression (Transcription);RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription;Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA (Consensus)

Intolerance Scores

loftool
0.0688
rvis_EVS
-1.59
rvis_percentile_EVS
3.05

Haploinsufficiency Scores

pHI
hipred
Y
hipred_score
0.563
ghis
0.681

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.847

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Srrt
Phenotype
endocrine/exocrine gland phenotype; cellular phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; immune system phenotype;

Zebrafish Information Network

Gene name
srrt
Affected structure
mandibular arch skeleton
Phenotype tag
abnormal
Phenotype quality
increased thickness

Gene ontology

Biological process
mRNA splicing, via spliceosome;regulation of transcription, DNA-templated;cell population proliferation;primary miRNA processing;snRNA transcription by RNA polymerase II;response to arsenic-containing substance;positive regulation of neurogenesis;neuronal stem cell population maintenance
Cellular component
nucleoplasm;cytoplasm;protein-containing complex
Molecular function
DNA binding;RNA binding;protein binding